vs

Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and Revolve Group, Inc. (RVLV). Click either name above to swap in a different company.

Revolve Group, Inc. is the larger business by last-quarter revenue ($324.4M vs $164.7M, roughly 2.0× PTC THERAPEUTICS, INC.). Revolve Group, Inc. runs the higher net margin — 5.7% vs -82.0%, a 87.7% gap on every dollar of revenue. On growth, Revolve Group, Inc. posted the faster year-over-year revenue change (10.4% vs -22.7%). Revolve Group, Inc. produced more free cash flow last quarter ($-13.3M vs $-36.6M). Over the past eight quarters, Revolve Group, Inc.'s revenue compounded faster (9.5% CAGR vs -11.5%).

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

Revolve Theatre Company is a Henley-on-Thames based theatre company specialising in political and Shakespearean plays. The company is owned by Oliver Dench, Joe Morris and Tom Smith.

PTCT vs RVLV — Head-to-Head

Bigger by revenue
RVLV
RVLV
2.0× larger
RVLV
$324.4M
$164.7M
PTCT
Growing faster (revenue YoY)
RVLV
RVLV
+33.2% gap
RVLV
10.4%
-22.7%
PTCT
Higher net margin
RVLV
RVLV
87.7% more per $
RVLV
5.7%
-82.0%
PTCT
More free cash flow
RVLV
RVLV
$23.4M more FCF
RVLV
$-13.3M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
RVLV
RVLV
Annualised
RVLV
9.5%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PTCT
PTCT
RVLV
RVLV
Revenue
$164.7M
$324.4M
Net Profit
$-135.0M
$18.6M
Gross Margin
53.3%
Operating Margin
-43.3%
6.3%
Net Margin
-82.0%
5.7%
Revenue YoY
-22.7%
10.4%
Net Profit YoY
-104.8%
50.4%
EPS (diluted)
$-1.63
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTCT
PTCT
RVLV
RVLV
Q4 25
$164.7M
$324.4M
Q3 25
$211.0M
$295.6M
Q2 25
$178.9M
$309.0M
Q1 25
$1.2B
$296.7M
Q4 24
$213.2M
$293.7M
Q3 24
$196.8M
$283.1M
Q2 24
$186.7M
$282.5M
Q1 24
$210.1M
$270.6M
Net Profit
PTCT
PTCT
RVLV
RVLV
Q4 25
$-135.0M
$18.6M
Q3 25
$15.9M
$21.2M
Q2 25
$-64.8M
$10.2M
Q1 25
$866.6M
$11.8M
Q4 24
$-65.9M
$12.3M
Q3 24
$-106.7M
$11.0M
Q2 24
$-99.2M
$15.4M
Q1 24
$-91.6M
$10.9M
Gross Margin
PTCT
PTCT
RVLV
RVLV
Q4 25
53.3%
Q3 25
54.6%
Q2 25
54.1%
Q1 25
52.0%
Q4 24
52.5%
Q3 24
51.2%
Q2 24
54.0%
Q1 24
52.3%
Operating Margin
PTCT
PTCT
RVLV
RVLV
Q4 25
-43.3%
6.3%
Q3 25
1.4%
7.1%
Q2 25
-19.5%
5.8%
Q1 25
82.5%
5.0%
Q4 24
-76.2%
3.9%
Q3 24
-27.7%
5.0%
Q2 24
-21.5%
5.8%
Q1 24
-21.6%
3.4%
Net Margin
PTCT
PTCT
RVLV
RVLV
Q4 25
-82.0%
5.7%
Q3 25
7.5%
7.2%
Q2 25
-36.3%
3.3%
Q1 25
73.7%
4.0%
Q4 24
-30.9%
4.2%
Q3 24
-54.2%
3.9%
Q2 24
-53.1%
5.4%
Q1 24
-43.6%
4.0%
EPS (diluted)
PTCT
PTCT
RVLV
RVLV
Q4 25
$-1.63
$0.27
Q3 25
$0.20
$0.29
Q2 25
$-0.83
$0.14
Q1 25
$10.04
$0.16
Q4 24
$-0.85
$0.18
Q3 24
$-1.39
$0.15
Q2 24
$-1.29
$0.21
Q1 24
$-1.20
$0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTCT
PTCT
RVLV
RVLV
Cash + ST InvestmentsLiquidity on hand
$1.9B
$292.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-205.3M
$512.5M
Total Assets
$2.9B
$765.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTCT
PTCT
RVLV
RVLV
Q4 25
$1.9B
$292.3M
Q3 25
$1.7B
$315.4M
Q2 25
$2.0B
$310.7M
Q1 25
$2.0B
$300.8M
Q4 24
$1.1B
$256.6M
Q3 24
$1.0B
$252.8M
Q2 24
$1.1B
$244.7M
Q1 24
$884.8M
$273.4M
Stockholders' Equity
PTCT
PTCT
RVLV
RVLV
Q4 25
$-205.3M
$512.5M
Q3 25
$-155.8M
$490.2M
Q2 25
$-206.5M
$468.6M
Q1 25
$-185.8M
$453.4M
Q4 24
$-1.1B
$437.8M
Q3 24
$-1.1B
$420.8M
Q2 24
$-980.2M
$405.8M
Q1 24
$-893.9M
$389.9M
Total Assets
PTCT
PTCT
RVLV
RVLV
Q4 25
$2.9B
$765.0M
Q3 25
$2.6B
$751.3M
Q2 25
$2.6B
$722.9M
Q1 25
$2.7B
$713.9M
Q4 24
$1.7B
$665.5M
Q3 24
$1.8B
$670.9M
Q2 24
$1.9B
$657.8M
Q1 24
$1.8B
$650.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTCT
PTCT
RVLV
RVLV
Operating Cash FlowLast quarter
$-34.3M
$-10.2M
Free Cash FlowOCF − Capex
$-36.6M
$-13.3M
FCF MarginFCF / Revenue
-22.3%
-4.1%
Capex IntensityCapex / Revenue
1.4%
1.0%
Cash ConversionOCF / Net Profit
-0.55×
TTM Free Cash FlowTrailing 4 quarters
$702.3M
$48.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTCT
PTCT
RVLV
RVLV
Q4 25
$-34.3M
$-10.2M
Q3 25
$-66.3M
$11.8M
Q2 25
$-58.3M
$12.6M
Q1 25
$870.1M
$45.1M
Q4 24
$-30.0M
$3.9M
Q3 24
$-77.0M
$9.1M
Q2 24
$-71.5M
$-24.7M
Q1 24
$70.8M
$38.4M
Free Cash Flow
PTCT
PTCT
RVLV
RVLV
Q4 25
$-36.6M
$-13.3M
Q3 25
$-69.7M
$7.5M
Q2 25
$-59.6M
$10.4M
Q1 25
$868.4M
$43.4M
Q4 24
$-33.8M
$2.1M
Q3 24
$-77.5M
$8.0M
Q2 24
$-78.8M
$-25.7M
Q1 24
$61.2M
$36.7M
FCF Margin
PTCT
PTCT
RVLV
RVLV
Q4 25
-22.3%
-4.1%
Q3 25
-33.1%
2.5%
Q2 25
-33.3%
3.4%
Q1 25
73.8%
14.6%
Q4 24
-15.8%
0.7%
Q3 24
-39.4%
2.8%
Q2 24
-42.2%
-9.1%
Q1 24
29.1%
13.5%
Capex Intensity
PTCT
PTCT
RVLV
RVLV
Q4 25
1.4%
1.0%
Q3 25
1.6%
1.5%
Q2 25
0.7%
0.7%
Q1 25
0.1%
0.6%
Q4 24
1.8%
0.6%
Q3 24
0.3%
0.4%
Q2 24
4.0%
0.4%
Q1 24
4.6%
0.6%
Cash Conversion
PTCT
PTCT
RVLV
RVLV
Q4 25
-0.55×
Q3 25
-4.17×
0.56×
Q2 25
1.24×
Q1 25
1.00×
3.82×
Q4 24
0.32×
Q3 24
0.83×
Q2 24
-1.60×
Q1 24
3.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PTCT
PTCT

Segment breakdown not available.

RVLV
RVLV

Fashion Apparel$155.1M48%
Dresses$76.4M24%
Handbags Shoes And Accessories$67.6M21%
Beauty$20.3M6%
Manufactured Product Other$5.0M2%
Breakage On Store Credit And Gift Cards$900.0K0%

Related Comparisons